全文获取类型
收费全文 | 7649篇 |
免费 | 757篇 |
国内免费 | 1篇 |
专业分类
8407篇 |
出版年
2022年 | 55篇 |
2021年 | 95篇 |
2020年 | 77篇 |
2019年 | 72篇 |
2018年 | 110篇 |
2017年 | 94篇 |
2016年 | 170篇 |
2015年 | 265篇 |
2014年 | 267篇 |
2013年 | 405篇 |
2012年 | 488篇 |
2011年 | 492篇 |
2010年 | 307篇 |
2009年 | 291篇 |
2008年 | 438篇 |
2007年 | 418篇 |
2006年 | 428篇 |
2005年 | 375篇 |
2004年 | 370篇 |
2003年 | 369篇 |
2002年 | 336篇 |
2001年 | 126篇 |
2000年 | 158篇 |
1999年 | 133篇 |
1998年 | 94篇 |
1997年 | 77篇 |
1996年 | 71篇 |
1995年 | 69篇 |
1994年 | 66篇 |
1993年 | 67篇 |
1992年 | 97篇 |
1991年 | 85篇 |
1990年 | 98篇 |
1989年 | 79篇 |
1988年 | 70篇 |
1987年 | 66篇 |
1986年 | 46篇 |
1985年 | 71篇 |
1984年 | 58篇 |
1983年 | 56篇 |
1982年 | 45篇 |
1981年 | 49篇 |
1980年 | 46篇 |
1979年 | 52篇 |
1978年 | 55篇 |
1977年 | 49篇 |
1976年 | 38篇 |
1975年 | 48篇 |
1974年 | 47篇 |
1972年 | 39篇 |
排序方式: 共有8407条查询结果,搜索用时 15 毫秒
991.
Ni YG Di Marco S Condra JH Peterson LB Wang W Wang F Pandit S Hammond HA Rosa R Cummings RT Wood DD Liu X Bottomley MJ Shen X Cubbon RM Wang SP Johns DG Volpari C Hamuro L Chin J Huang L Zhao JZ Vitelli S Haytko P Wisniewski D Mitnaul LJ Sparrow CP Hubbard B Carfí A Sitlani A 《Journal of lipid research》2011,52(1):78-86
Proprotein convertase subtilisin-like/kexin type 9 (PCSK9) regulates LDL cholesterol levels by inhibiting LDL receptor (LDLr)-mediated cellular LDL uptake. We have identified a fragment antigen-binding (Fab) 1D05 which binds PCSK9 with nanomolar affinity. The fully human antibody 1D05-IgG2 completely blocks the inhibitory effects of wild-type PCSK9 and two gain-of-function human PCSK9 mutants, S127R and D374Y. The crystal structure of 1D05-Fab bound to PCSK9 reveals that 1D05-Fab binds to an epitope on the PCSK9 catalytic domain which includes the entire LDLr EGF(A) binding site. Notably, the 1D05-Fab CDR-H3 and CDR-H2 loops structurally mimic the EGF(A) domain of LDLr. In a transgenic mouse model (CETP/LDLr-hemi), in which plasma lipid and PCSK9 profiles are comparable to those of humans, 1D05-IgG2 reduces plasma LDL cholesterol to 40% and raises hepatic LDLr protein levels approximately fivefold. Similarly, in healthy rhesus monkeys, 1D05-IgG2 effectively reduced LDL cholesterol 20%-50% for over 2 weeks, despite its relatively short terminal half-life (t(1/2) = 3.2 days). Importantly, the decrease in circulating LDL cholesterol corresponds closely to the reduction in free PCSK9 levels. Together these results clearly demonstrate that the LDL-lowering effect of the neutralizing anti-PCSK9 1D05-IgG2 antibody is mediated by reducing the amount of PCSK9 that can bind to the LDLr. 相似文献
992.
993.
Donato Spoltore Wibren D. Oosterbaan Samira Khelifi John N. Clifford Aurelien Viterisi Emilio Palomares Marc Burgelman Laurence Lutsen Dirk Vanderzande Jean Manca 《Liver Transplantation》2013,3(4):466-471
The non‐geminate recombination of charge carriers in polymer‐fullerene solar cells has been modeled in the last few years with a trap‐assisted recombination model, which states that the apparent recombination order depends on the concentration of trapped charges tailing into the band gap. Higher concentrations of trapped charges lead to higher apparent recombination orders. In this work, the mass fraction f of highly crystalline nanofibrillar P3HT to the total P3HT content in P3HT:PCBM solar cells is consistently varied, controlling the temperature of a nanofibers‐P3HT casting dispersion. A systematic study of the apparent recombination order, measured with a transient photovoltage technique, as a function of f is presented. A correlation is shown between the apparent recombination order, the P3HT crystallinity, and the trap concentration in the band gap measured with an admittance spectroscopy technique. 相似文献
994.
Ping Zhang Jennifer Guergues Amy R. Alleyne Thomas J. Cirino Owen Nadeau Ariana M. Figueroa Heather M. Stacy Takayoshi Suzuki Jay P. McLaughlin Stanley M. Stevens Jr Bin Liu 《Proteomics》2022,22(9):2100137
As the resident immune cells in the central nervous system, microglia play an important role in the maintenance of its homeostasis. Dysregulation of microglia has been associated with the development and maintenance of chronic pain. However, the relevant molecular pathways remain poorly defined. In this study, we used a mass spectrometry-based proteomic approach to screen potential changes of histone protein modifications in microglia isolated from the brain of control and cisplatin-induced neuropathic pain adult C57BL/6J male mice. We identified several novel microglial histone modifications associated with pain, including statistically significantly decreased histone H3.1 lysine 27 mono-methylation (H3.1K27me1, 54.8% of control) and H3 lysine 56 tri-methylation (7.5% of control), as well as a trend suggesting increased H3 tyrosine 41 nitration. We further investigated the functional role of H3.1K27me1 and found that treatment of cultured microglial cells for 4 consecutive days with 1–10 μM of NCDM-64, a potent and selective inhibitor of lysine demethylase 7A, an enzyme responsible for the demethylation of H3K27me1, dose-dependently elevated its levels with a greater than a two-fold increase observed at 10 μM compared to vehicle-treated control cells. Moreover, pretreatment of mice with NCDM-64 (10 or 25 mg/kg/day, i.p.) prior to cisplatin treatment prevented the development of neuropathic pain in mice. The identification of specific chromatin marks in microglia associated with chronic pain may yield critical insight into the contribution of microglia to the development and maintenance of pain, and opens new avenues for the development of novel nonopioid therapeutics for the effective management of chronic pain. 相似文献
995.
Xinzhong Li Andrew J. Buckton Samuel L. Wilkinson Shibu John Roddy Walsh Tomas Novotny Iveta Valaskova Manu Gupta Laurence Game Paul J R. Barton Stuart A. Cook James S. Ware 《PloS one》2013,8(7)
Background
Molecular genetic testing is recommended for diagnosis of inherited cardiac disease, to guide prognosis and treatment, but access is often limited by cost and availability. Recently introduced high-throughput bench-top DNA sequencing platforms have the potential to overcome these limitations.Methodology/Principal Findings
We evaluated two next-generation sequencing (NGS) platforms for molecular diagnostics. The protein-coding regions of six genes associated with inherited arrhythmia syndromes were amplified from 15 human samples using parallelised multiplex PCR (Access Array, Fluidigm), and sequenced on the MiSeq (Illumina) and Ion Torrent PGM (Life Technologies). Overall, 97.9% of the target was sequenced adequately for variant calling on the MiSeq, and 96.8% on the Ion Torrent PGM. Regions missed tended to be of high GC-content, and most were problematic for both platforms. Variant calling was assessed using 107 variants detected using Sanger sequencing: within adequately sequenced regions, variant calling on both platforms was highly accurate (Sensitivity: MiSeq 100%, PGM 99.1%. Positive predictive value: MiSeq 95.9%, PGM 95.5%). At the time of the study the Ion Torrent PGM had a lower capital cost and individual runs were cheaper and faster. The MiSeq had a higher capacity (requiring fewer runs), with reduced hands-on time and simpler laboratory workflows. Both provide significant cost and time savings over conventional methods, even allowing for adjunct Sanger sequencing to validate findings and sequence exons missed by NGS.Conclusions/Significance
MiSeq and Ion Torrent PGM both provide accurate variant detection as part of a PCR-based molecular diagnostic workflow, and provide alternative platforms for molecular diagnosis of inherited cardiac conditions. Though there were performance differences at this throughput, platforms differed primarily in terms of cost, scalability, protocol stability and ease of use. Compared with current molecular genetic diagnostic tests for inherited cardiac arrhythmias, these NGS approaches are faster, less expensive, and yet more comprehensive. 相似文献996.
997.
Elena P. Sawin Laurence R. Harris Ana R. Campos Marla B. Sokolowski 《Journal of Insect Behavior》1994,7(4):553-567
In this paper we examine theDrosophila melanogaster larval response to light. We survey the morphology of the larval visual and motor systems in relation to larval locomotory behavior and phototaxis. In addition, this paper proposes a model of sensorimotor transformation and examines the reversal in taxis occurring at theD. melanogaster larval wnadering stage. 相似文献
998.
999.
New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes 下载免费PDF全文
Dodé C Le Dû N Cuisset L Letourneur F Berthelot JM Vaudour G Meyrier A Watts RA Scott DG Nicholls A Granel B Frances C Garcier F Edery P Boulinguez S Domergues JP Delpech M Grateau G 《American journal of human genetics》2002,70(6):1498-1506
Mutations of CIAS1 have recently been shown to underlie familial cold urticaria (FCU) and Muckle-Wells syndrome (MWS), in three families and one family, respectively. These rare autosomal dominant diseases are both characterized by recurrent inflammatory crises that start in childhood and that are generally associated with fever, arthralgia, and urticaria. The presence of sensorineural deafness that occurs later in life is characteristic of MWS. Amyloidosis of the amyloidosis-associated type is the main complication of MWS and is sometimes associated with FCU. In FCU, cold exposure is the triggering factor of the inflammatory crisis. We identified CIAS1 mutations, all located in exon 3, in nine unrelated families with MWS and in three unrelated families with FCU, originating from France, England, and Algeria. Five mutations--namely, R260W, D303N, T348M, A439T, and G569R--were novel. The R260W mutation was identified in two families with MWS and in two families with FCU, of different ethnic origins, thereby demonstrating that a single CIAS1 mutation may cause both syndromes. This result indicates that modifier genes are involved in determining either a MWS or a FCU phenotype. The finding of the G569R mutation in an asymptomatic individual further emphasizes the importance of such modifier a gene (or genes) in determining the disease phenotype. Identification of this gene (or these genes) is likely to have significant therapeutic implications for these severe diseases. 相似文献
1000.